We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
–
AUM
$772M
AUM Growth
+$48.7M
Cap. Flow
+$20.1M
Cap. Flow %
2.6%
Top 10 Hldgs %
48.69%
Holding
66
New
1
Increased
25
Reduced
7
Closed
3

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$17.8M
2
IDXX icon
Idexx Laboratories
IDXX
+$14.2M
3
MCD icon
McDonald's
MCD
+$14M
4
PYPL icon
PayPal
PYPL
+$3.5M
5
BDX icon
Becton Dickinson
BDX
+$2.69M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$13.3M
2
EW icon
Edwards Lifesciences
EW
+$12.4M
3
CVS icon
CVS Health
CVS
+$6.65M
4
ISRG icon
Intuitive Surgical
ISRG
+$5.93M
5
EMR icon
Emerson Electric
EMR
+$2.81M

Sector Composition

Rank Sector Weight
1 Technology 28.22%
2 Financials 13.97%
3 Healthcare 13.58%
4 Consumer Discretionary 13.16%
5 Industrials 11.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMT icon
51
Lockheed Martin
LMT
$134B
$705K 0.09%
1,450
– –
PEP icon
52
PepsiCo
PEP
$194B
$674K 0.09%
4,433
– –
AMGN icon
53
Amgen
AMGN
$211B
$586K 0.08%
2,250
– –
DE icon
54
Deere & Co
DE
$171B
$584K 0.08%
1,379
– –
CL icon
55
Colgate-Palmolive
CL
$74.9B
$545K 0.07%
6,000
– –
ABT icon
56
Abbott
ABT
$187B
$485K 0.06%
4,289
– –
NKE icon
57
Nike
NKE
$63.9B
$469K 0.06%
6,200
– –
RTX icon
58
RTX Corp
RTX
$292B
$365K 0.05%
3,151
– –
WMT icon
59
Walmart Inc
WMT
$904B
$361K 0.05%
4,000
– –
AVGO icon
60
Broadcom
AVGO
$1.8T
$348K 0.05%
1,500
– –
BMY icon
61
Bristol-Myers Squibb
BMY
$130B
$258K 0.03%
4,557
– –
JNJ icon
62
Johnson & Johnson
JNJ
$645B
$246K 0.03%
1,700
– –
XOM icon
63
ExxonMobil
XOM
$635B
$225K 0.03%
2,090
– –
CVS icon
64
CVS Health
CVS
$139B
– –
-105,770
Closed -$6.65M
EW icon
65
Edwards Lifesciences
EW
$48.2B
– –
-187,562
Closed -$12.4M
WDC icon
66
Western Digital
WDC
$157B
– –
-39,690
Closed -$2.05M
1 2
3

Similar funds

LPC
Long Pond Capital New York $1.05B AUM 16.49% 1-Year Est. Return
HWCM
Hudson Way Capital Management Dallas, Texas $1.05B AUM 6.84% 1-Year Est. Return
AA
Apriem Advisors Irvine, California $1.05B AUM 22.09% 1-Year Est. Return
CIA
CCM Investment Advisers Columbia, South Carolina $1.04B AUM 40.82% 1-Year Est. Return
CIA
Compass Ion Advisors Conshohocken, Pennsylvania $1.05B AUM 16.28% 1-Year Est. Return
SPC
Spirepoint Private Client Vero Beach, Florida $1.05B AUM 22.43% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.04B AUM 21.13% 1-Year Est. Return

Waycross Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Waycross Partners held 66 positions worth $772M, up 6.7% from $723M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Waycross Partners's Q4 2024 filing shows 1 new, 25 increased, 7 reduced and 3 closed positions. Its largest new stake was Idexx Laboratories: 32,438 shares worth $13.4M. The largest sale was Visa, an estimated $13.3M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

  • Waycross Partners's largest Q4 2024 buy was Idexx Laboratories: 32,438 shares worth $13.4M.
  • Waycross Partners added most to Boeing in Q4 2024, an estimated $17.8M increase.
  • Waycross Partners's biggest Q4 2024 reduction was Visa, cutting an estimated $13.3M.
  • Waycross Partners fully exited Edwards Lifesciences in Q4 2024, selling an estimated $12.4M.
  • Waycross Partners's ten largest holdings make up 49% of its $772M portfolio in Q4 2024.
  • Waycross Partners opened 1 new position and closed 3 in Q4 2024.
  • Waycross Partners's portfolio value rose 6.7% quarter-over-quarter to $772M.

Based on Waycross Partners's 13F filing for Q4 2024, filed 31 Jan 2025.